NPA Advocacy

The National Perinatal Association advocates for improved perinatal care through a variety of advocacy activities. We publish position papers, guidelines, sign amicus curaie briefs, and statements which  support  or oppose legislation related to health and well being in the perinatal period. 


NEWS: NPA Submits a Letter to the FDA

This April the National Perinatal Association submitted a statement to the Gastrointestinal Drugs Advisory Committee and the Pediatric Advisory Committee of the FDA in support of new innovations in treatment for infants with hyperbilirubemia. 

"The National Perinatal Association supports innovation in the treatment of all neonatal medical conditions including hyperbilirubemia. We commend Mallinckrodt for the development of the first medication to treat hyperbilirubemia in many decades. Hyperbilirubemia treatment currently requires separation of mother and infant. This impacts the attachment process for the dyad, breastfeeding and causes significant anxiety and distress for parents and families. Best practices in dyad care emphasizes close physical contact of mother and infant. Treatments that support these best practices are critical to positive outcomes. In addition, as you know hyperbilirubemia is the leading cause of hospital re-admission for infants under 30 days of age. Innovative treatments that can maintain the physical contact of mother and infant and decrease re-hospitalization for hyperbilirubemia are needed."

Read our statement here. 

When appropriate, NPA will take the lead on issues in order to raise awareness and promote support. From its inception, however, NPA has believed in a "coalition of advocacy" and has partnered with many organizations including the March of Dimes, ACOG, AAP, and ACNM to name just a few. Some advocacy issues for NPA include family support, bereavement, palliative care, quality improvement, the promotion of "normal" birth, preconception health, access to care, and medical liability reform.

In keeping with the mission of NPA, the board will not endorse products and services; however, the Board is willing to provide expertise to:

    • Consult on the development of health care policies and practices which affect mothers, infants, young children as well as their caretakers and health care providers
    • Review proposals for programs and policies intended to benefit mothers, infants and young children as well as their caretakers and health care providers
    • Review requests for endorsements of educational periodicals and position statements from other professional, service and volunteer organizations
    • Review and consider support for positions, amicus briefs, etc. on public policy issues

NPA strives to ensure that in all cases its review considers the mission of NPA, respects the broad make-up of its members,
and upholds strict ethical standards.
© 2020 National Perinatal Association
Powered by Wild Apricot Membership Software